MedTrace Logo

Targeting Diet-Microbiome Interactions in the Pathogenesis of Parkinson's Disease

NCT03705520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2023-06-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the microbiome of medicated and non-medicated subjects diagnosed with Parkinson's disease. Where available, in comparison to the microbiome of a healthy spouse or 1st degree relative.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • California Institute of Technology

    collaborator OTHER

  • Purdue University

    collaborator OTHER

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Ali Keshavarzian, MD · Rush University Medical Center

  • Gian Pal, MD · Rush Univeristy Medical Center

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-05
Primary Completion
2022-08-31
Completion
2023-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03705520 on ClinicalTrials.gov